Literature DB >> 24577949

Impact of right-ventricular apical pacing on the optimal left-ventricular lead positions measured by phase analysis of SPECT myocardial perfusion imaging.

Guang-Uei Hung1, Jin-Long Huang, Wan-Yu Lin, Shih-Chung Tsai, Kuo-Yang Wang, Shih-Ann Chen, Michael S Lloyd, Ji Chen.   

Abstract

PURPOSE: The use of SPECT phase analysis to optimize left-ventricular (LV) lead positions for cardiac resynchronization therapy (CRT) was performed at baseline, but CRT works as simultaneous right ventricular (RV) and LV pacing. The aim of this study was to assess the impact of RV apical (RVA) pacing on optimal LV lead positions measured by SPECT phase analysis.
METHODS: This study prospectively enrolled 46 patients. Two SPECT myocardial perfusion scans were acquired under sinus rhythm with complete left bundle branch block and RVA pacing, respectively, following a single injection of (99m)Tc-sestamibi. LV dyssynchrony parameters and optimal LV lead positions were measured by the phase analysis technique and then compared between the two scans.
RESULTS: The LV dyssynchrony parameters were significantly larger with RVA pacing than with sinus rhythm (p ~0.01). In 39 of the 46 patients, the optimal LV lead positions were the same between RVA pacing and sinus rhythm (kappa = 0.861). In 6 of the remaining 7 patients, the optimal LV lead positions were along the same radial direction, but RVA pacing shifted the optimal LV lead positions toward the base.
CONCLUSION: The optimal LV lead positions measured by SPECT phase analysis were consistent, no matter whether the SPECT images were acquired under sinus rhythm or RVA pacing. In some patients, RVA pacing shifted the optimal LV lead positions toward the base. This study supports the use of baseline SPECT myocardial perfusion imaging to optimize LV lead positions to increase CRT efficacy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24577949     DOI: 10.1007/s00259-014-2693-y

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  31 in total

1.  Cardiac resynchronization in chronic heart failure.

Authors:  William T Abraham; Westby G Fisher; Andrew L Smith; David B Delurgio; Angel R Leon; Evan Loh; Dusan Z Kocovic; Milton Packer; Alfredo L Clavell; David L Hayes; Myrvin Ellestad; Robin J Trupp; Jackie Underwood; Faith Pickering; Cindy Truex; Peggy McAtee; John Messenger
Journal:  N Engl J Med       Date:  2002-06-13       Impact factor: 91.245

2.  Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony.

Authors:  James A White; Raymond Yee; Xiaping Yuan; Andrew Krahn; Allan Skanes; Michele Parker; George Klein; Maria Drangova
Journal:  J Am Coll Cardiol       Date:  2006-10-31       Impact factor: 24.094

3.  Tissue Doppler velocity is superior to displacement and strain mapping in predicting left ventricular reverse remodelling response after cardiac resynchronisation therapy.

Authors:  C-M Yu; Q Zhang; Y-S Chan; C-K Chan; G W K Yip; L C C Kum; E B Wu; P-W Lee; Y-Y Lam; S Chan; J W-H Fung
Journal:  Heart       Date:  2006-04-18       Impact factor: 5.994

4.  Repeatability of left ventricular dyssynchrony and function parameters in serial gated myocardial perfusion SPECT studies.

Authors:  Xianhe Lin; Huiqin Xu; Xuefeng Zhao; Russell D Folks; Ernest V Garcia; Prem Soman; Ji Chen
Journal:  J Nucl Cardiol       Date:  2010-05-04       Impact factor: 5.952

5.  Impact of biventricular pacing on mortality in a randomized crossover study of patients with heart failure and ventricular arrhythmias.

Authors:  I Lozano; M Bocchiardo; M Achtelik; F Gaita; H J Trappe; E Daoud; J Hummel; C Duby; P Yong
Journal:  Pacing Clin Electrophysiol       Date:  2000-11       Impact factor: 1.976

6.  A prospective pilot study to evaluate the relationship between acute change in left ventricular synchrony after cardiac resynchronization therapy and patient outcome using a single-injection gated SPECT protocol.

Authors:  Mati Friehling; Ji Chen; Samir Saba; Raveen Bazaz; David Schwartzman; Evan C Adelstein; Ernest Garcia; William Follansbee; Prem Soman
Journal:  Circ Cardiovasc Imaging       Date:  2011-07-19       Impact factor: 7.792

Review 7.  Imaging in cardiac resynchronization therapy: what does the clinician need?

Authors:  Erwan Donal; Christian de Chillou; Isabelle Magnin-Poull; Christophe Leclercq
Journal:  Europace       Date:  2008-11       Impact factor: 5.214

8.  The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Authors:  John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

Review 9.  Cardiac resynchronization therapy guided by cardiovascular magnetic resonance.

Authors:  Francisco Leyva
Journal:  J Cardiovasc Magn Reson       Date:  2010-11-09       Impact factor: 5.364

Review 10.  Selecting patients for cardiac resynchronization therapy: electrical or mechanical dyssynchrony?

Authors:  Nathaniel M Hawkins; Mark C Petrie; Michael R MacDonald; Kerry J Hogg; John J V McMurray
Journal:  Eur Heart J       Date:  2006-03-09       Impact factor: 29.983

View more
  3 in total

1.  Biventricular pacing in heart failure: right is not wrong!

Authors:  Prem Soman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-06       Impact factor: 9.236

2.  Impact of cardiac reverse remodeling after cardiac resynchronization therapy assessed by myocardial perfusion imaging on ventricular arrhythmia.

Authors:  Kuo-Feng Chiang; Guang-Uei Hung; Shih-Chung Tsai; Chien-Ming Cheng; Yu-Cheng Chang; Wan-Yu Lin; Yu-Cheng Hsieh; Tsu-Juey Wu; Shih-Ann Chen; Jin-Long Huang; Ying-Chieh Liao; Ji Chen
Journal:  J Nucl Cardiol       Date:  2016-03-15       Impact factor: 5.952

3.  LV Dyssynchrony Is Helpful in Predicting Ventricular Arrhythmia in Ischemic Cardiomyopathy After Cardiac Resynchronization Therapy: A Preliminary Study.

Authors:  Shih-Chuan Tsai; Yu-Cheng Chang; Kuo-Feng Chiang; Wan-Yu Lin; Jin-Long Huang; Guang-Uei Hung; Chia-Hung Kao; Ji Chen
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.